Effect of fluoxetine on seizures in rats with high susceptibility to audiogenic stress
Background: The seizures, triggered by a loud sound in laboratory animals, are associated with the imbalance of the brain monoamines. Serotonin (5-HT) is regarded as one of the principal neurotransmitters to be involved in regulation of wide variety of physiological and psychological processes. Among the drugs that affect 5-HT synaptic transmission, the leading role is given to selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine.
Aim: The aim of the study is to investigate the effects of fluoxetine on seizures in Wistar rats with high susceptibility to audiogenic stress. Methods: The study was performed on male Wistar rats. Prior to the experiments, the animals were tested for susceptibility to audiogenic seizures by exposure to a sound of 90-110 dB for 2 min in the soundproof box. The difference between congenital susceptibility to seizures served as a basis for dividing animals into 2 groups: seizure-susceptible (SS) and seizure-tolerant (ST) rats. One h prior to the experiment, the experimental animals were orally administered with fluoxetine, while the control rats were treated with distilled water. The effect of fluoxetine on the level of the biogenic amines in different regions of the brain was determined by enzyme-linked immunosorbent assay (ELISA).
Results: It has been shown that in 100% of the cases, the control SS rats, exposed to audiogenic stimulus, exhibited wild running around in circles and jumping as some of the signs of seizure responses that evolved into tonic-clonic seizures in 70% of the cases. As regards the experimental SS animals: only in 60% of the cases (р<0.05) they exhibited wild running and flinch, which did not evolve into the tonic-clonic phase.
Conclusions: Decreased manifestation of seizures in the experimental SS rats under acute administration of fluoxetine may be explained by highly distinctive repertoire and spatial distribution of 5-HT receptors in their brain structures in comparison to the ST rats.
Relevance for patients: The study of the monoaminergic mechanisms of seizure generation is of practical importance due to the existence of pharmacological agents, which selectively affect the activity of the monoaminergic systems of the brain, as well as the metabolism of the monoamines synthesized by them.
[1] Kuznezova GD, Spiridonov AM. The Mapping of SpikeWave Discharges in WAG/Rij Rats (a Genetic Strain of Absence Epilepsy). Zh Vyssh Nerv Deiat Im I P Pavlova 1998;48:664-70.
[2] Doretto MC, Fonseca CG, Lobo RB, Terra VC, Oliveira JA, Garcia-Cairasco N. Quantitative Study of the Response to Genetic Selection of the Wistar Audiogenic Rat Strain (WAR). Behav Genet 2003;33:33-42.
[3] Rudolf G, Bihoreau MT, Godfrey RF, Wilder SP, Cox RD, Lathrop M, et al. Polygenic Control of Idiopathic Generalized Epilepsy Phenotypes in the Genetic Absence Rats from Strasbourg (GAERS). Epilepsia 2004;45:301-8.
[4] Ross KS, Coleman JR. Developmental and Genetic Audiogenic Seizure Models: Behavior and Biological Substrates. Neurosci Biobehav Rev 2000;24:639-53.
[5] Jobe PC, Mishra PK, Ludvig N, Dailey JW. Genetic Models of the Epilepsies. In: Schwartzkroin PA, editor. Epilepsy: Models, Mechanisms, and Concepts. Cambridge: University Press; 1993. p. 94-140.
[6] Malikova LA, Narkevich VB, Klodt PM, Kudrin VS, Raevskii KS, Fedotova IB, Poletaeva II. Effects of the Novel Anticonvulsant Levetiracetam on the Content of Monoamines and their Main Metabolites in the Brain Structures of Rats of the Krushinskii-Molodkina Strain. Neurochem J 2008;2:289-92.
[7] Poletaeva II, Surina NM, Kostina ZA, Perepelkina OV, Fedotova IB. The Krushinsky-Molodkina Rat Strain: The Study of Audiogenic Epilepsy for 65 Years. Epilepsy Behav 2017;71:130-41.
[8] Ismayilova KhYu, Aghayev TM, Semenova TP. Individual Peculiarities of Behavior (Monoaminergic Mechanisms). Baku, Azerbaijan: Nurlan Press 2007. p. 228.
[9] Gromova EA, Semenov TP, Chubakov AR, Bobkova NV. Reciprocity of the Relationship between Serotonergic and Noradrenergic Systems of the Brain and its Role in the Regulation of Behavior at Norm and Pathology; 1985.
[10] Boer JA. Social Anxiety Disorder/Social Phobia: Epidemiology, Diagnosis, Neurobiology, and Treatment. Compr Psychiatry 2000;41:405-15.
[11] Wong DT, Perry KW, Bymaster FP. Case History: The Discovery of Fluoxetine Hydrochloride (Prozac). Nat Rev Drug Discov 2005;4:764-74.
[12] Shishkina GT. Neuroadaptive Changes in the Brain Under the Effects of the Serotonin Reuptake Blockers. Russ J Physiol 2007;93:1245-51.
[13] Kuznezova GD. Audiogenic Seizures in the Different Genetic Strains of Rats. Pavlov J High Nerv Act 1998;48:143-52.
[14] Sarkisova KY, Fedotova IB, Surina NM, Nikolaev GM, Perepelkina OV, Kostina ZA, et al. Genetic Background Contributes to the Co-Morbidity of Anxiety and Depression with Audiogenic Seizure Propensity and Responses to Fluoxetine Treatment. Epilepsy Behav 2017;68:95-102.
[15] Bosak M, Turaj W, Dudek D, Siwek M, Szczudlik A. Depressogenic Medications and Other Risk Factors for Depression among Polish Patients with Epilepsy. Neuropsychiatr Dis Treat 2015;11:2509-17.
[16] Shaw FZ, Chuang SH, Shieh KR, Wang YJ. Depressionand Anxiety-Like Behaviors of a Rat Model with Absence Epileptic Discharges. Neuroscience 2009;160:382-93.
[17] Meerson FZ, Mamalyga LM. The Protective Action of Adaptation to Hypoxia in Audiogenic Epilepsy and its Prolongation by using Pharmacologic Agents. Bull ExpBiol Med 1994;117:120-3.
[18] Poletaeva II. Audiogenic Epilepsy in Rodents. Nature 2017;9:40-7.
[19] Shishkina GT, Dygalo NN, Yudina AM, Kalinina TS, Tolstikova TG, Sorokina IV, et al. The Effects of Fluoxetine and Its Complexes with Glycerrhizic Acid on Behavior in Rats and Brain Monoamine Levels. Neurosci Behav Physiol 2006;36:329-33.
[20] Dygalo NN, Shishkina GT, Kalinina TS, Yudina AM, Ovchinnikova ES. Effect of Repeated Treatment with Fluoxetine on Tryptophan Hydroxylase-2 Gene Expression in the Rat Brainstem. Pharmacol Biochem Behav 2006;85:220-7.
[21] Kovalenko IL, Avgustinovich DF, Tolstikova TG. Effects of Single and Chronic Administration of Fluoxetine on Anxiety-Depressive Male and Female Mice. Ross Physiol J 2007;93:1401-12.
[22] Simonov PV. Individual Brain. Structural Foundations of Individual Characteristics of Behavior. Russia: Nauka; 1993. p. 3-7.
[23] Bazyan AS, Grigoryan GA, Ioffe ME. Regulation of Motor Behavior. Adv Physiol Sci 2011;42:65-80.
[24] Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A. Dopaminergic Contribution to the Regulation of Emotional Perception. Clin Neuropharmacol 2005;28:228-37.
[25] Glickstein SB, Schmauss C. Dopamine Receptor Functions: Lessons from Knockout Mice. Pharmacol Ther 2001;91:63-83.
[26] Hervas I, Vilaro MT, Romero L, Scorza MC, Mengod G, Artigas F. Desensitization of 5-HT1A Autoreceptors by a Low Chronic Fluoxetine dose Effect of the Concurrent Administration of WAY-100635. Neuropsychopharmacology 2001;24:11-20.
[27] Furlan PM, Kallan MJ, Have TT, Lucki I, Katz I. SSRIs do not Cause Affective Blunting in Healthy Elderly Volunteers. Am J Geriatr Psychiatry 2004;12:323-30.
[28] Мurphy DL, Lerner A, Rudnick G, Lesch KP. Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics. Mol Interv 2004;4:109-23.
[29] Harkin A, Shanahan E, Kelly JP, Connor TJ. Methylenendioxyamphetamine Produces Serotonin Nerve Terminal Loss and Diminished Behavioural and Neurochemical Responses to the Antidepressant Fluoxetine. Eur J Neurosci 2003;18:1021-7.
[30] Dailey JW, Yan QS, Adams-Curtis LE, Ryu JR, Ko KH, Mishra PK, et al. Neurochemical Correlates of Antiepileptic Drugs in the Genetically Epilepsy-Prone Rat (GEPR). Life Sci 1996;58:259-66.
[31] Sparks DL, Buckholtz NS. Combined Inhibition of Serotonin Uptake and Oxidative Deamination Attenuates Audiogenic Seizures in DBA/2J Mice. Pharmacol Biochem Behav 1985;23:753-7.
[32.] Freitas RM, Sousa FC, Viana GS, Fonteles MM. Effect of GABAergic, Glutamatergic, Antipsychotic and Antidepressant Drugs on Pilocarpine-Induced Seizures and Status Epilepticus. Neurosci Lett 2006;408:79-83.
[33] Aygun H. The Effect of Fluoxetine on Penicillin-Induced Epileptiform Activity. Epilepsy Behav 2019;95:79-86.
[34] Ferrero AJ, Cereseto M, Reinés A, Bonavita CD, Sifonios LL, Rubio MC, et al. Chronic Treatment with Fluoxetine Decreases Seizure Threshold in Naive but not in Rats Exposed to the Learned Helplessness Paradigm: Correlation with the Hippocampal Glutamate Release. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:678-86.
[35] Treiman DM. GABAergic Mechanisms in Epilepsy. Epilepsia 2001;42:8-12.
[36] Hovorka J, Herman E, Nemcova I. Treatment of Interictal Depression with Citalopram in Patients with Epilepsy. Epilepsy Behav 2000;1:444-7.
[37] Lebedeva AV. Peculiarities of Depression in Patients with Epilepsy. Med J Russ Fed 2007;10:892.
[38] Yan QS, Dailey JW, Steenbergen JL, Jobe PC. Anticonvulsant Effect of Enhancement of Noradrenergic Transmission in the Superior Colliculus in Genetically Epilepsy-Prone Rats (GEPRs): A Microinjection Study. Brain Res 1998;780:199-209.
[39] Dovedova EL, Monakov MY. Metabolism of Neurotransmitters in Cortical and Subcortical Brain Structures in Rats with Different Behavioral Characteristics. Bull Exp Biol Med 2000;130:861-3.
[40] Gorbunova AV. The Autonomic Nervous System and Resistance of the Cardio-Vascular Functions to Emotional Stress. Neurochemistry 2000;17:163-84.
[41] Ungar G. Is There a Chemical Memory Trace? Isr J Chem 1975;14:160-76.
[42] Kulagin DA, Bolondinski VK. Neurochemical Aspects of the Emotional Reactivity and Motor Activity of Rats in New Circumstances. Front Physiol Sci 1986;17:92-109.
[43] Okuhara DY, Beck SG. 5-HT1А Receptor Linked to Inward-Rectifying Potassium Current in Hippocampal CA3 Pyramidal Cells. J Neurophysiol 1994;71:2161-7.
[44] Kanner AM. Depression in Epilepsy: Prevalence, Clinical Semiology, Pathogenic Mechanisms, and Treatment. Biol Psychiatry 2003;54:388-98.
[45] Statnick MA, Maring-Smith ML, Clough RW, Wang C, Dailey JW, Jobe PC, et al. Effect of 5, 7-Dihydroxytryptamine on Audiogenic Seizures in Genetically Epilepsy-Prone Rats. Life Sci 1996;59:1763-71.
[46] Richerson GB. Serotonergic Neurons as Carbon Dioxide Sensors that Maintain pH Homeostasis. Nat Rev Neurosci 2004;5:449-61.
[47] Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and Epilepsy. J Neurochem 2007;100:857-73.
[48] Faingold CL, Randall M, Zeng C, Peng S, Long X, Feng HJ. Serotonergic Agents act of 5-HT3 Receptors in the Brain to Block Seizure-Induced Respiratory Arrest in the DBA/1 Mouse Model of SUDEP. Epilepsy Behav 2016;64:166-70.
[49] Venit EL, Shepard BD, Seyfried TN. Oxygenation Prevents Sudden Death in Seizure-Prone Mice. Epilepsia 2004;45:993-6.
[50] Tupal S, Faingold CL. Evidence Supporting a Role of Serotonin in Modulation of Sudden Death Induced by Seizures in DBA/2 Mice. Epilepsia 2006;47:21-6.
[51] Pasini A, Tortorella A, Gale K. The Anticonvulsant Action of Fluoxetine in Substantia Nigra is Dependent upon Endogenous Serotonin. Brain Res 1996;724:84-8.